Francesco Callegarin, Health researcher at the Veneto Oncology Institute IOV – IRCCS, shared on LinkedIn:
“I am thrilled to share that I had the opportunity to present our poster at the XXVIII AIOM National Congress 2026 in Rome.
Our work, titled ‘Financial Toxicity After Robot-Assisted Surgery for Urological Malignancies: The UROFIT Study’ explores the financial burden experienced by patients undergoing robot-assisted surgery for urological cancers.
Even within universal healthcare systems, treatment-related expenses, indirect costs, and work disruptions can significantly impact patients’ quality of life and recovery.
Raising awareness and identifying vulnerable patient subgroups early on is essential to providing truly comprehensive, patient-centered oncology care.
Presenting the UROFIT study at AIOM 2026 was a wonderful opportunity, connect with fellow researchers and clinicians, and gain fresh perspectives on the future of oncology.
It was truly a wonderful congress, filled with inspiring sessions and valuable scientific exchange.
A heartfelt thank you to Antonio Amodeo as Principal Investigator of UROFIT study and Giuliana Lista, and everyone involved in making this project possible!”
About AIOM 2026
The XXVIII National Congress of the Italian Association of Medical Oncology (AIOM 2026) took place on November 13–15, 2026, at the Rome Marriott Park Hotel in Rome, Italy. Bringing together medical oncologists, researchers and healthcare professionals, the congress provided a platform for scientific exchange and discussion of advances across the field of oncology.
The 2026 edition was guided by the theme “Innovazione Equa” (Equitable Innovation), emphasizing the importance of ensuring that progress in cancer research, diagnosis and treatment translates into accessible, equitable care, while addressing existing healthcare disparities and preventing new ones.
Organized by the Italian Association of Medical Oncology (AIOM), the congress serves as a key meeting point for the Italian and international oncology community, encouraging collaboration and the integration of scientific innovation into clinical practice.
You can also read: Muna Al-Khaifi Explores Financial Toxicity in Cancer Care
